Anti-infective agents useful against multidrug-resistant strains of bacteria
US6946446B2 · kind B2 · utility
21Cited by
9References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 23, 2001 |
| Grant date | Sep 20, 2005 |
| Priority date | — |
| Expiry date | Feb 23, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/335
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel methods for using macrolide anti-infective agents. The macrolide anti-infective agents demonstrate antibacterial activity against multi-drug resistant strains of bacteria and, in particular, methicillin-resistant Staphylococcus aureus (MRSA). Methods for inhibiting the activity of multi-drug resistant bacterial organisms and methods for treating a bacterial infection caused by such organisms are described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.